<DOC>
	<DOCNO>NCT02870205</DOCNO>
	<brief_summary>Study evaluate efficacy , safety tolerability GSP 301 NS compare placebo NS individual monotherapy formulation treatment Seasonal Allergic Rhinitis ( subject 12 year age old )</brief_summary>
	<brief_title>Efficacy Safety GSP 301 Nasal Spray Treatment Seasonal Allergic Rhinitis ( SAR )</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Seasonal</mesh_term>
	<mesh_term>Olopatadine Hydrochloride</mesh_term>
	<criteria>Males nonpregnant female 12 year age old . Documented clinical history SAR ( least 2 year precede Screening Visit [ Visit 1 ] ) exacerbation ( clinical evidence active symptom ) relevant seasonal allergen Fall mountain cedar allergy season ( e.g. , ragweed mountain cedar pollen ) A 12hour rTNSS ≥8 possible 12 congestion score ≥2 AM assessment Screening Visit ( Visit 1 ) . Pregnant lactating woman . History anaphylaxis and/or severe local reaction ( ) skin test . History positive test HIV , Hepatitis B Hepatitis C infection . Documented evidence acute significant chronic sinusitis chronic purulent postnasal drip . Subjects active pulmonary disorder infection . Subjects posterior subcapsular cataract glaucoma Plans travel outside know pollen area investigational site 24 hour longer last 7 day runin period .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>